The randomized double-blind, placebo-controlled investigation, designed to evaluate the efficacy of 25 ml/kg intravenous NuPlasma young Fresh Frozen Plasma (yFFP®) administered in two doses over three days, continues to realize dramatic and statistically significant improvements.
Ultimately, for patients treated with yFFP, there were a number of Motor Symptom reductions observed during in-person neurologist-assessments at 6 months, including action tremor (-80.6), tremor at rest (-50.8%) and a number of instances of improved bradykinesia, including postural stability (-62.5%) and body bradykinesia (-25%).